Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ozkan Akhan"'
Serum HDL Associated Antioxidant Activity in Alzheimer's Disease: Paraoxonase1 and Dysfunctional HDL
Publikováno v:
Clinical laboratory. 66(9)
Background Human serum paraoxonase1 (PON1) is a high-density lipoprotein (HDL) associated antioxidant enzymes. We aimed to research the PON1 activity in Alzheimer's disease (AD) not accompanied with any disorders and other conditions influencing the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01bd0e01870dd990b1bb4c4a182025f4
https://pubmed.ncbi.nlm.nih.gov/32902236
https://pubmed.ncbi.nlm.nih.gov/32902236
Autor:
Hideki Sugihara, Masaharu Ichikawa, Jin Woo Choi, Wei Chen, Hahn Young Kim, Tanvir Chowdhury Turin, Fumie Konoeda, Laura Mechtouff, Ja-Hae Kim, Kossivi Apetse, Yoshikuni Kita, Yohsuke Yagi, Toshiki Mizuno, Yutaka Morita, Myeong-Kyu Kim, Jean Philippe Neau, Byeong-Chae Kim, Hong Gee Roh, Roger Gil, Pille Taba, R.H.B. Benedict, Ozkan Akhan, Pierre Ingrand, Tae-Hee Cho, Young Jin Kim, D.W. Langdon, Takuya Yagi, Gulbun Yuksel, Francis Turjman, S.F. Xue, Hidehiro Mizusawa, K. Beckmann, Yasuyuki Nakamura, Man-Seok Park, Hyun-Ji Cho, S. Fredrikson, Satz Mengensatzproduktion, Naoyuki Takashima, Takanori Yokota, Hirotsugu Ueshima, Joon-Tae Kim, Figen Varlibas, Nobuo Sanjo, J.P. Jia, Kunihiko Hirose, Jin-Hua Zhang, Seong-Min Choi, Nahid Rumana, Andrew J. Lees, Norihiro Suzuki, Xing-Yue Hu, Ikuko Mizuta, Kang-Ho Choi, Gerald Stern, Mireille Beauchamps, Eva Maria Arroyo-Anlló, Ki-Hyun Cho, Seung-Han Lee, Druck Reinhardt Druck Basel, X. Ma, Laurent Derex, Li-San Zhang, E.M. Wicklein, Lin-Yan Yao, Li-Li Wei, Young Il Chun, Murat Can, Q.F. Ma, Katsuyuki Miura, Yu Geng, Joon Hwa Lee, Berrak Guven, Norbert Nighoghossian, Akira Okayama
Publikováno v:
European Neurology. 69:I-IV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13982cf3a221c2e4a0da2bb8f1dab2c8
https://doi.org/10.1159/000353288
https://doi.org/10.1159/000353288
Objectives: The objective of this study was to determine ischemia modified albumin (IMA) and oxidant status in Alzheimer's disease (AD). Therefore, we evaluated the IMA and oxidant status by measuring serum uric acid, albumin and gamma-glutamyltransf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49970c6f0c0d8c30fe041b5deaa1e8c5
https://hdl.handle.net/20.500.12628/6412
https://hdl.handle.net/20.500.12628/6412
